Ahead of Prostate Cancer Awareness Month, the most common cancer among men, here is everything about the new treatment already in use in Israel that brings hope to patients.

“Most folks who are diagnosed with them end up dying from them, usually within a year or two. We don't have great treatments.

Cancer cells have many strategies for resisting therapy. One such strategy is survivin, a protein that drives the division of diseased cells and prevents them from dying.

By Koh Hyunjeong A domestic research team in a world first has created a molecular revert switch that restores cancer cells ...

Using tiny particles shaped like bottlebrushes, MIT chemists have found a way to deliver a large range of chemotherapy drugs ...

Chronic inflammation is tingly associated with numerous types of cancer. While not everyone with it will develop cancer, ...

A South Korean research team has developed the first-ever "molecular reversion switch" technology that returns cancer cells ...

Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the United ...

Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the United ...

Former President Joe Biden has gone under the knife (and the microscope) to remove skin cancer lesions. Biden’s spokesperson, ...

UB researchers and collaborators have completed a series of studies that reveal how much painful mouth sores known as oral ...